1009 participants
Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-16
- Start Date:
- 2022-11-28
- Completion:
- 2025-05-22
Conditions
- Sexually Transmitted Diseases
Interventions
- BIOLOGICAL
- COMBINATION_PRODUCT